Publications by authors named "Claudia Maturo"

Claim this Profile
A
A phase I study of the first-in-class antimitochondrial metabolism agent, CPI-613, in patients with advanced hematologic malignancies.
Timothy S Pardee, King Lee, John Luddy, Claudia Maturo, Robert Rodriguez

Clin Cancer Res· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translational assessment of mitochondrial dysfunction of pancreatic cancer from in vitro gene microarray and animal efficacy studies, to early clinical studies, via the novel tumor-specific anti-mitochondrial agent, CPI-613.
King C Lee, Claudia Maturo, Candida N Perera, John Luddy, Robert Rodriguez

Ann Transl Med· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-redox-active lipoate derivates disrupt cancer cell mitochondrial metabolism and are potent anticancer agents in vivo.
Zuzana Zachar, James Marecek, Claudia Maturo, Sunita Gupta, Shawn D Stuart

J Mol Med (Berl)· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formation and anti-tumor activity of uncommon in vitro and in vivo metabolites of CPI-613, a novel anti-tumor compound that selectively alters tumor energy metabolism.
King C Lee, Robert Shorr, Robert Rodriguez, Claudia Maturo, Lakmal W Boteju

Drug Metab Lett· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanomedicine-nanoemulsion formulation improves safety and efficacy of the anti-cancer drug paclitaxel according to preclinical assessment.
King C Lee, Claudia Maturo, Robert Rodriguez, Hoang-Lan Nguyen, Robert Shorr

J Nanosci Nanotechnol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis